Could DMT Be a New Treatment for Depression? A Small Study Says Yes

People taking DMT tended to experience significant relief from their depression for up to three months, the researchers found ...

NRx Builds Momentum From FDA Progress To Strategic Expansion

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...

Just one dose of psychedelic drug reduced depression in a week: Study

Researchers reported rapid, significant improvement in depression, with the benefits lasting for months after treatment.

NRx Pharmaceuticals (Nasdaq:NRXP) Announces Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting

NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of ...
Stocktwits on MSN

CMPS stock jumps 22% pre-market as Compass sets timeline for new phase 3 depression trial results

Compass announced in January that the FDA had accepted its Investigational New Drug application for COMP360 for the treatment ...

Magic Mushroom Ingredient Passes Major Test, Paving Way for FDA Approval

In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.
New Atlas

First US at-home depression kit on its way after trial shows relief in weeks

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...
Scientific American

Is There New Hope for Treating Postpartum Depression?

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. The birth of a child comes with a swirl of positive emotions: awe, joy, relief. And yet, ...